FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3201513519> ?p ?o ?g. }

• W3201513519 endingPage "e002954" @default.
• W3201513519 startingPage "e002954" @default.
• W3201513519 abstract "Background Metformin (Met) is the first-line treatment for type 2 diabetes mellitus and plays an effective role in treating various diseases, such as cardiovascular disease, neurodegenerative disease, cancer, and aging. However, the underlying mechanism of Met-dependent antitumor immunity remains to be elucidated. Methods MitoTEMPO, a scavenger of mitochondrial superoxide, abolished the antitumor effect of Met, but not antiprogrammed cell death (PD-1) antibody (Ab) treatment. Consequently, we studied the mechanism of the Met-induced antitumor effect. Expressions of glucose transporter (Glut)-1, mitochondrial reactive oxygen species (mtROS), interferon (IFN)-γ, Ki67, autophagy markers, activation markers for NF-E2-related factor 2 (Nrf2), and mammalian target of rapamaycin complex 1 (mTORC1) in CD8 + tumor-infiltrating T lymphocytes (CD8TILs) were examined by flow cytometry analysis. In addition, conditional knockout mice for Nrf2 and p62 were used to detect these markers, together with the monitoring of in vivo tumor growth. RNA sequencing was performed for CD8TILs and tumor cells. Melanoma cells containing an IFN-γ receptor (IFNγR) cytoplasmic domain deletion mutant was overexpressed and used for characterization of the metabolic profile of those tumor cells using a Seahorse Flux Analyzer. Results Met administration elevates mtROS and cell surface Glut-1, resulting in the production of IFN-γ in CD8TILs. mtROS activates Nrf2 in a glycolysis-dependent manner, inducing activation of autophagy, glutaminolysis, mTORC1, and p62/SQSTM1. mTORC1-dependent phosphorylation of p62 at serine 351 (p-p62(S351)) is also involved in activation of Nrf2. Conditional deletion of Nrf2 in CD8TILs abrogates mTORC1 activation and antitumor immunity by Met. In synergy with the effect of anti-PD-1 Ab, Met boosts CD8TIL proliferation and IFN-γ secretion, resulting in decreased glycolysis and oxidative phosphorylation in tumor cells. Consequently, Glut-1 is elevated in CD8TILs, together with the expansion of activated dendritic cells. Moreover, tumor cells lacking in IFNγR signaling abolish IFN-γ production and proliferation of CD8TILs. Conclusions We found that Met stimulates production of mtROS, which triggers Glut-1 elevation and Nrf2 activation in CD8TILs. Nrf2 activates mTORC1, whereas mTORC1 activates Nrf2 in a p-p62(S351)-dependent manner, thus creating a feedback loop that ensures CD8TILs’ proliferation. In combination with anti-PD-1 Ab, Met stimulates robust proliferation of CD8TILs and IFN-γ secretion, resulting in an IFN-γ-dependent reprogramming of the tumor microenvironment." @default.
• W3201513519 created "2021-09-27" @default.
• W3201513519 creator A5006914306 @default.
• W3201513519 creator A5009414246 @default.
• W3201513519 creator A5013524621 @default.
• W3201513519 creator A5023890424 @default.
• W3201513519 creator A5027472355 @default.
• W3201513519 creator A5028244539 @default.
• W3201513519 creator A5029772199 @default.
• W3201513519 creator A5035706905 @default.
• W3201513519 creator A5036296341 @default.
• W3201513519 creator A5041051001 @default.
• W3201513519 creator A5086773725 @default.
• W3201513519 creator A5089569598 @default.
• W3201513519 date "2021-09-01" @default.
• W3201513519 modified "2023-10-18" @default.
• W3201513519 title "Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes" @default.
• W3201513519 cites W1839349418 @default.
• W3201513519 cites W1967540945 @default.
• W3201513519 cites W1967727543 @default.
• W3201513519 cites W1972806358 @default.
• W3201513519 cites W1992962914 @default.
• W3201513519 cites W1994993231 @default.
• W3201513519 cites W2022675211 @default.
• W3201513519 cites W2026967508 @default.
• W3201513519 cites W2046178144 @default.
• W3201513519 cites W2053047691 @default.
• W3201513519 cites W2058881502 @default.
• W3201513519 cites W2079683011 @default.
• W3201513519 cites W2092340120 @default.
• W3201513519 cites W2100039832 @default.
• W3201513519 cites W2112818491 @default.
• W3201513519 cites W2119437574 @default.
• W3201513519 cites W2121225884 @default.
• W3201513519 cites W2122639773 @default.
• W3201513519 cites W2144910957 @default.
• W3201513519 cites W2148755064 @default.
• W3201513519 cites W2156370651 @default.
• W3201513519 cites W2160411684 @default.
• W3201513519 cites W2160551785 @default.
• W3201513519 cites W2160571820 @default.
• W3201513519 cites W2217461794 @default.
• W3201513519 cites W2281758534 @default.
• W3201513519 cites W2340338776 @default.
• W3201513519 cites W2467811750 @default.
• W3201513519 cites W2476838381 @default.
• W3201513519 cites W2519020116 @default.
• W3201513519 cites W2522313999 @default.
• W3201513519 cites W2560185130 @default.
• W3201513519 cites W2589009607 @default.
• W3201513519 cites W2592666036 @default.
• W3201513519 cites W2622890446 @default.
• W3201513519 cites W2743010525 @default.
• W3201513519 cites W2763979809 @default.
• W3201513519 cites W2767159687 @default.
• W3201513519 cites W2791235391 @default.
• W3201513519 cites W2791369805 @default.
• W3201513519 cites W2792043029 @default.
• W3201513519 cites W2793286226 @default.
• W3201513519 cites W2800324021 @default.
• W3201513519 cites W2809965878 @default.
• W3201513519 cites W2903012995 @default.
• W3201513519 cites W2968141411 @default.
• W3201513519 cites W2969352988 @default.
• W3201513519 cites W3006508170 @default.
• W3201513519 cites W565843157 @default.
• W3201513519 doi "https://doi.org/10.1136/jitc-2021-002954" @default.
• W3201513519 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8449974" @default.
• W3201513519 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34531248" @default.
• W3201513519 hasPublicationYear "2021" @default.
• W3201513519 type Work @default.
• W3201513519 sameAs 3201513519 @default.
• W3201513519 citedByCount "34" @default.
• W3201513519 countsByYear W32015135192021 @default.
• W3201513519 countsByYear W32015135192022 @default.
• W3201513519 countsByYear W32015135192023 @default.
• W3201513519 crossrefType "journal-article" @default.
• W3201513519 hasAuthorship W3201513519A5006914306 @default.
• W3201513519 hasAuthorship W3201513519A5009414246 @default.
• W3201513519 hasAuthorship W3201513519A5013524621 @default.
• W3201513519 hasAuthorship W3201513519A5023890424 @default.
• W3201513519 hasAuthorship W3201513519A5027472355 @default.
• W3201513519 hasAuthorship W3201513519A5028244539 @default.
• W3201513519 hasAuthorship W3201513519A5029772199 @default.
• W3201513519 hasAuthorship W3201513519A5035706905 @default.
• W3201513519 hasAuthorship W3201513519A5036296341 @default.
• W3201513519 hasAuthorship W3201513519A5041051001 @default.
• W3201513519 hasAuthorship W3201513519A5086773725 @default.
• W3201513519 hasAuthorship W3201513519A5089569598 @default.
• W3201513519 hasBestOaLocation W32015135191 @default.
• W3201513519 hasConcept C121608353 @default.
• W3201513519 hasConcept C134018914 @default.
• W3201513519 hasConcept C185592680 @default.
• W3201513519 hasConcept C2778160063 @default.
• W3201513519 hasConcept C2778175917 @default.
• W3201513519 hasConcept C2780323712 @default.
• W3201513519 hasConcept C28859421 @default.
• W3201513519 hasConcept C48349386 @default.

• next